Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Enterprise Value (2021 - 2026)

Valneva SE (VALN) posted Enterprise Value of -$123.2 million for Q1 2026, up 3.45% sequentially from -$127.6 million in Q4 2025, and up 23.42% YoY from -$99.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Enterprise Value (2021 - 2026) Analysis & Trends

Valneva SE has reported Enterprise Value for 8 years, with the latest figure at -$123.2 million in Q1 2026.

  • Quarterly Enterprise Value rose 23.42% year-over-year to -$123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$123.2 million (up 23.42% YoY) and the FY2025 annual result came in at -$127.6 million, up 30.44% from the prior year.
  • Enterprise Value advanced to -$123.2 million in Q1 2026 per VALN's latest filing, from -$127.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$123.2 million in Q1 2026 and troughed at -$358.8 million in Q2 2022.
  • A 5-year average of -$207.7 million and a median of -$184.1 million in 2025 frame the typical range for Enterprise Value.
  • The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 638756.95% in 2022, then jumped 53.6% in 2023.
  • Over 5 years, Enterprise Value stood at -$292.3 million in 2022, then surged by 53.6% to -$135.7 million in 2023, then slumped by 33.54% to -$181.2 million in 2024, then advanced by 29.54% to -$127.6 million in 2025, then climbed by 3.45% to -$123.2 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$123.2 million, -$127.6 million, and -$167.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 312.55 Mn
Mar 31, 2026 419.07 Mn
Dec 31, 2025 637.67 Mn
Sep 30, 2025 823.67 Mn
Jun 30, 2025 227.36 Mn
Mar 31, 2025 384.33 Mn
Dec 31, 2024 123.46 Mn
Sep 30, 2024 247.82 Mn
Jun 30, 2024 345.37 Mn
Mar 31, 2024 358.20 Mn
Dec 31, 2023 522.12 Mn
Sep 30, 2023 614.72 Mn
Jun 30, 2023 731.63 Mn
Mar 31, 2023 435.98 Mn
Dec 31, 2022 515.87 Mn
Sep 30, 2022 268.01 Mn
Jun 30, 2022 835.14 Mn
Mar 31, 2022 1.45 Bn
Dec 31, 2021 2.92 Bn
Sep 30, 2021 1.13 Bn